Preferred Label : methylphenidate hydrochloride;

UMLS semantic type : T109 - Organic Chemical; T121 - Pharmacologic Substance;

CAS number : 298-59-9; 4B3SC438HI;

Codes EINECS : 206-065-3;

Is substance : O;

UNII : 4B3SC438HI;

InChIKey : JUMYIBMBTDDLNG-OJERSXHUSA-N;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3419448/fr/concerta-lp-methylphenidate-trouble-deficitaire-de-l-attention-avec-hyperactivite-tdah-chez-l-adulte
2023
false
false
false
France
administration, oral
Delayed-Action preparations
treatment outcome
insurance, health, reimbursement
methylphenidate hydrochloride
Adult attention deficit hyperactivity disorder (disorder)
evaluation of the transparency committee
adult
methylphenidate
attention deficit disorder with hyperactivity

---
https://www.has-sante.fr/jcms/p_3210094/fr/quasym-lp
2020
false
false
false
France
methylphenidate hydrochloride
treatment outcome
insurance, health, reimbursement
central nervous system stimulants
methylphenidate
child
attention deficit disorder with hyperactivity
continuity of patient care
critical pathways
case management
evaluation of the transparency committee
methylphenidate

---
https://www.has-sante.fr/jcms/p_3210115/fr/medikinet
2020
false
false
false
France
methylphenidate hydrochloride
methylphenidate
treatment outcome
insurance, health, reimbursement
attention deficit disorder with hyperactivity
child
continuity of patient care
critical pathways
central nervous system stimulants
case management
evaluation of the transparency committee
methylphenidate

---
https://www.has-sante.fr/jcms/p_3210109/fr/concerta-lp
2020
false
false
false
France
methylphenidate
methylphenidate hydrochloride
treatment outcome
insurance, health, reimbursement
attention deficit disorder with hyperactivity
child
central nervous system stimulants
guidelines for drug use
continuity of patient care
critical pathways
case management
evaluation of the transparency committee
methylphenidate

---
https://www.has-sante.fr/jcms/p_3210112/fr/ritaline-ritaline-lp
2020
false
false
false
France
treatment outcome
insurance, health, reimbursement
child
attention deficit disorder with hyperactivity
continuity of patient care
critical pathways
case management
methylphenidate
adult
narcolepsy
evaluation of the transparency committee
methylphenidate hydrochloride
methylphenidate

---
https://www.has-sante.fr/portail/jcms/c_2897010/en/ritaline-ritaline-lp
2018
true
France
French
narcolepsy
methylphenidate
narcotics
Delayed-Action preparations
central nervous system stimulants
administration, oral
methylphenidate
attention deficit disorder with hyperactivity
insurance, health, reimbursement
child
adolescent
treatment outcome
capsules
methylphenidate hydrochloride
evaluation of the transparency committee

---
https://www.has-sante.fr/portail/jcms/c_2893478/fr/medikinet
2018
true
France
French
methylphenidate
insurance, health, reimbursement
administration, oral
treatment outcome
methylphenidate
methylphenidate hydrochloride
central nervous system stimulants
narcotics
attention deficit disorder with hyperactivity
Delayed-Action preparations
evaluation of the transparency committee
child
continuity of patient care

---
http://www.has-sante.fr/portail/jcms/c_2621698/fr/quasym-lp
http://www.has-sante.fr/portail/jcms/c_2621698/fr/quasym-lp-methylphenidate-psychostimulant
2016
true
France
English
French
guidelines for drug use
child
adolescent
methylphenidate
sympathomimetics
treatment outcome
insurance, health, reimbursement
central nervous system stimulants
narcotics
methylphenidate
Delayed-Action preparations
administration, oral
attention deficit disorder with hyperactivity
methylphenidate hydrochloride
evaluation of the transparency committee

---
http://www.avisdexperts.ch/videos/view/1688/1
2014
false
false
false
Switzerland
French
methylphenidate
attention deficit disorder with hyperactivity
child
central nervous system stimulants
methylphenidate hydrochloride
methylphenidate
methylphenidate hydrochloride
central nervous system stimulants
video recording

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61810983
2013
summary of product characteristics
methylphenidate hydrochloride
capsules
Ritalin
methylphenidate

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61145640
2013
France
summary of product characteristics
methylphenidate
methylphenidate hydrochloride
capsules

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65754838
2013
France
summary of product characteristics
methylphenidate hydrochloride
tablets
methylphenidate

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64211191
2013
France
summary of product characteristics
methylphenidate
methylphenidate hydrochloride
capsules

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66592983
2013
France
summary of product characteristics
capsules
methylphenidate hydrochloride
methylphenidate

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63657828
2013
France
summary of product characteristics
methylphenidate hydrochloride
capsules
methylphenidate

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64836257
2013
France
summary of product characteristics
methylphenidate hydrochloride
methylphenidate
tablets

---
http://www.meddispar.fr/Medicaments/RITALINE-LP-10-FL-28/(type)/letter/(value)/R/(cip)/3400941686535
2013
France
French
drug information
methylphenidate hydrochloride
methylphenidate
methylphenidate
drug prescriptions
legislation, drug
administration, oral
Delayed-Action preparations
narcotics

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65942167
2013
France
summary of product characteristics
methylphenidate hydrochloride
methylphenidate
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63000533
2013
France
summary of product characteristics
methylphenidate hydrochloride
capsules
methylphenidate

---
http://www.has-sante.fr/portail/jcms/c_1334808/quasym
http://www.has-sante.fr/portail/jcms/c_1336054/quasym-03102012-avis-ct12435
http://www.has-sante.fr/portail/jcms/c_939181/quasym
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-02/quasym__ct_7544.pdf
2012
France
French
English
administration, oral
insurance, health, reimbursement
methylphenidate
central nervous system stimulants
methylphenidate
sympathomimetics
Delayed-Action preparations
narcotics
child
attention deficit disorder with hyperactivity
methylphenidate hydrochloride
treatment outcome
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_1334799/ritaline
http://www.has-sante.fr/portail/upload/docs/evamed/CT-12083_RITALINE_03102012_AVIS_CT12083.pdf
http://www.has-sante.fr/portail/jcms/c_399926/ritaline-lp-20-mg-gelules-boite-de-30-ritaline-lp-30-mg-gelules-boite-de-30-ritaline-lp-40-mg-gelules-boite-de-30
2012
false
France
French
methylphenidate
narcotics
Delayed-Action preparations
central nervous system stimulants
administration, oral
methylphenidate
attention deficit disorder with hyperactivity
insurance, health, reimbursement
child
adolescent
treatment outcome
capsules
methylphenidate hydrochloride
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_1334823/concerta
http://www.has-sante.fr/portail/upload/docs/evamed/CT-12439_CONCERTA_03102012_AVIS_CT12439.pdf
http://www.has-sante.fr/portail/jcms/c_750923/concerta
2012
France
French
methylphenidate
central nervous system stimulants
attention deficit disorder with hyperactivity
methylphenidate
Delayed-Action preparations
administration, oral
narcotics
insurance, health, reimbursement
child
adolescent
methylphenidate hydrochloride
treatment outcome
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_1334805/medikinet
http://www.has-sante.fr/portail/jcms/c_1334804/medikinet-03102012-avis-ct12144
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-11/methylphenidate_reeval_annexe.pdf
2012
false
France
French
methylphenidate
methylphenidate
insurance, health, reimbursement
administration, oral
treatment outcome
methylphenidate
methylphenidate hydrochloride
methylphenidate hydrochloride
central nervous system stimulants
central nervous system stimulants
narcotics
attention deficit disorder with hyperactivity
Delayed-Action preparations
evaluation of the transparency committee
child
continuity of patient care
therapeutic equivalency
randomized controlled trials as topic
Methylphenidate hydrochloride (product)

---
http://www.meddispar.fr/Medicaments/QUASYM-LP-10-B-28/(type)/letter/(value)/Q/(cip)/3400949726165
2011
France
French
administration, oral
narcotics
Delayed-Action preparations
drug prescriptions
legislation, drug
methylphenidate
methylphenidate
methylphenidate hydrochloride
drug information

---
http://www.meddispar.fr/Medicaments/QUASYM-LP-20-B-28/(type)/letter/(value)/Q/(cip)/3400949726226
2011
France
French
administration, oral
narcotics
drug prescriptions
legislation, drug
methylphenidate
Delayed-Action preparations
methylphenidate
methylphenidate hydrochloride
drug information

---
http://www.meddispar.fr/Medicaments/QUASYM-LP-30-B-28/(type)/letter/(value)/Q/(cip)/3400949726745
2011
France
French
administration, oral
narcotics
drug prescriptions
legislation, drug
methylphenidate
Delayed-Action preparations
methylphenidate
methylphenidate hydrochloride
drug information

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60059081
2010
France
French
methylphenidate
methylphenidate
central nervous system stimulants
central nervous system stimulants
administration, oral
tablets
methylphenidate
attention deficit disorder with hyperactivity
child
adolescent
narcolepsy
adult
drug interactions
pregnancy
breast feeding
dopamine uptake inhibitors
dopamine uptake inhibitors
drug evaluation, preclinical
methylphenidate hydrochloride
methylphenidate hydrochloride
summary of product characteristics
package leaflet

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60756917
2010
France
French
Delayed-Action preparations
tablets
administration, oral
methylphenidate
methylphenidate
methylphenidate
central nervous system stimulants
central nervous system stimulants
attention deficit disorder with hyperactivity
child
adolescent
drug interactions
pregnancy
breast feeding
dopamine uptake inhibitors
dopamine uptake inhibitors
drug evaluation, preclinical
drug therapy, combination
methylphenidate hydrochloride
methylphenidate hydrochloride
summary of product characteristics
package leaflet

---
http://www.has-sante.fr/portail/jcms/c_960947/quasym-lp-methylphenidate-psychostimulant
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-04/quasym_-_ct-7544.pdf
http://www.has-sante.fr/portail/jcms/c_939181/fr/quasym
2010
false
France
French
guidelines for drug use
child
adolescent
methylphenidate
sympathomimetics
treatment outcome
insurance, health, reimbursement
methylphenidate
sympathomimetics
central nervous system stimulants
narcotics
methylphenidate
Delayed-Action preparations
administration, oral
attention deficit disorder with hyperactivity
methylphenidate hydrochloride
methylphenidate hydrochloride
evaluation of the transparency committee

---
https://www.paediatrieschweiz.ch/fr/methylphenidate-et-abus/
2009
false
Switzerland
French
methylphenidate
central nervous system stimulants
dopamine uptake inhibitors
substance-related disorders
central nervous system stimulants
methylphenidate
dopamine uptake inhibitors
methylphenidate hydrochloride
journal article

---
http://www.meddispar.fr/medicaments/3392940
2008
France
French
methylphenidate
tablets
administration, oral
narcotics
drug prescriptions
legislation, drug
methylphenidate
methylphenidate hydrochloride
drug information

---
http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F35F05F
2008
Belgium
Dutch
French
methylphenidate
child
central nervous system stimulants
belgium
drug utilization review
methylphenidate
methylphenidate hydrochloride
journal article
drug information

---
http://www.meddispar.fr/medicaments/3653518
2008
France
French
narcotics
drug prescriptions
legislation, drug
capsules
methylphenidate
Delayed-Action preparations
administration, oral
methylphenidate
methylphenidate hydrochloride
drug information

---
http://www.meddispar.fr/medicaments/3615541
2008
France
French
administration, oral
methylphenidate
tablets
Delayed-Action preparations
drug prescriptions
legislation, drug
narcotics
methylphenidate
methylphenidate hydrochloride
drug information

---
http://www.meddispar.fr/medicaments/3653501
2008
France
French
methylphenidate
capsules
Delayed-Action preparations
administration, oral
narcotics
drug prescriptions
legislation, drug
methylphenidate
methylphenidate hydrochloride
drug information

---
http://www.meddispar.fr/medicaments/3615564
2008
France
French
administration, oral
methylphenidate
drug prescriptions
legislation, drug
tablets
Delayed-Action preparations
narcotics
methylphenidate
methylphenidate hydrochloride
drug information

---
http://www.meddispar.fr/medicaments/3615558
2008
France
French
methylphenidate
administration, oral
drug prescriptions
legislation, drug
tablets
Delayed-Action preparations
narcotics
methylphenidate
methylphenidate hydrochloride
drug information

---
http://www.has-sante.fr/portail/display.jsp?id=c_399886
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct031455.pdf
2003
France
French
guidelines for drug use
Delayed-Action preparations
administration, oral
methylphenidate
central nervous system stimulants
insurance, health, reimbursement
attention deficit disorder with hyperactivity
child
adolescent
treatment outcome
methylphenidate
narcotics
tablets
methylphenidate hydrochloride
evaluation of the transparency committee

---
Nous contacter.
29/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.